|
|
||||
![]() | ||||
|
|
|
Select from the search options to widen or narrow the search results.
TAILOR RX PACCT-1 The purpose of this study is to determine whether patients who have a tumor will benefit from chemotherapy, and to confirm patients who have a low risk of recurrence will benefit from hormonal therapy. Participants must:
For more information in Milwaukee/Slinger Please Contact, Pamela Rynes RN BSN CCRC at 414-649-6067 or pam.rynes@aurora.org Principal Investigator:Johnathan Treisman,MD For more information at Elkhorn, Please Contact, Carol Thomas BS, MT, CCRC at 414-649-5605 or carol.thomas@aurora.org Principal Investigator, Rosanna Madamba, MD For information at Aurora BayCare Medical Center contact Lori McElrone CCRC, 920-288-4174 or lori.mcelrone@aurora.org Principal Investigator, Dhiman Patel, MD For more information at Two Rivers please contact Mary Jo Lindemann, CRA 920-793-6106 maryjo.lindemann@aurora.org Principle Investigator: Andrew YetterM.D.
For more information at West Allis please contact Jill Auer RN,MSN, ONC 414-329-5945 jill.auer@aurora.org Principle Investigator: Magdalina Flejsierowicz M.D. Clinical trial location(s)AMG - ABMC (incl. VLCC)2845 Greenbrier Road Green Bay, WI 54308-8900 Aurora St. Luke's Medical Center VLCC - Elkhorn VLCC - Slinger VLCC- Oshkosh VLCC- Two Rivers West Allis Memorial Hospital
[ previous page ]
|
||
|
|
|
|||